2011
DOI: 10.1002/cncr.26405
|View full text |Cite
|
Sign up to set email alerts
|

Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women

Abstract: BACKGROUND: Breast tumors from African American women have less favorable pathological characteristics and higher mortality rates than those of Caucasian women. Although socioeconomic status may influence prognosis, biological factors are also likely to contribute to tumor behavior. METHODS: Patients with invasive breast cancer were matched by age, grade, and estrogen receptor status; patients with benign disease were matched by age and diagnosis type. RNA from laser microdissected tumors and whole-sectioned n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
84
1
3

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 75 publications
(94 citation statements)
references
References 40 publications
6
84
1
3
Order By: Relevance
“…RNA for microarray analysis was processed as previously described. 35 Labeled RNA was hybridized to HG U133A 2.0 arrays (Affymetrix, 900469) according to manufacturer's protocols.…”
Section: Patients/methods/materialsmentioning
confidence: 99%
“…RNA for microarray analysis was processed as previously described. 35 Labeled RNA was hybridized to HG U133A 2.0 arrays (Affymetrix, 900469) according to manufacturer's protocols.…”
Section: Patients/methods/materialsmentioning
confidence: 99%
“…This unusual mortality rate is due to its aggressive behavior and high metastatic nature that spreads to other parts of the body such as the lung, brain, and liver [22]. It is also well known that African American women struggle with high mortality rate associated with this cancer compared to women of European descent [23,24]. The highly aggressive nature of this cancer subtype can be characterized by high levels of cytokeratin 5, and cytokeratin 6 with high expression levels of epidermal growth factor receptor (EGFR) which pertain to basal-like carcinomas [19].…”
Section: Triple Negative Breast Cancermentioning
confidence: 99%
“…It has been shown previously that SOS1 is differentially expressed in prostate and breast cancer populations (7,8) and is required for Ras signaling and growth of human prostate cancer cells (7). Given the additive effects of combination treatment of UC-773587 and UC-857993 in our biochemical experiments, we used the SOS1-dependent human DU-145 prostate cancer cells as a model to examine whether combination treatment of our SOS1 inhibitors could additively inhibit growth of the DU-145 cancer cells.…”
Section: B-d and F)mentioning
confidence: 99%